Clinical Trials Directory

Trials / Unknown

UnknownNCT03939260

ECCO2R - Mechanical Power Study

The Effects of Low Flow Extracorporeal CO2 Removal on Mechanical Power in ARDS Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
15 (estimated)
Sponsor
University of Milan · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Although mechanical ventilation remains the cornerstone of ARDS treatment, several experimental and clinical studies have undoubtedly demonstrated that it can contribute to high mortality through the developing of ventilator induced lung injury even in patients with plateau pressure \<30 cmH2O. Since now there are no studies exploring the application of low flow extracorporeal CO2 removal and ultraprotective ventilation to reduce mechanical power, a composite index of VILI, independently from the value of plateau pressure or the severity of hypercapnia.

Conditions

Interventions

TypeNameDescription
OTHERExtracorporeal CO2 RemovalExtracorporeal carbon dioxide removal (ECCO2R), a low flow extracorporeal CO2 removal, may be used in association with ultraprotective mechanical ventilation (tidal volume \< 6 ml/kg and Pplat \<20-25 cmH2O).

Timeline

Start date
2019-03-20
Primary completion
2021-03-01
Completion
2024-03-01
First posted
2019-05-06
Last updated
2019-05-06

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT03939260. Inclusion in this directory is not an endorsement.